Antares Pharma, Inc. (ATRS)

Net Income Growth

-31.90%

TTM · Period ending:

ATRS logo

ATRS Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-31.90%
ATRS TTM Net Income YoY % (-32.75% → -31.90%)
High-resolution chart · PNG

ATRS net income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Antares Pharma, Inc. Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
-31.899%
-13.5692%
607.4448%
1,103.5451%
5,293.5986%
2,872.6196%
1,717.3469%
255.7892%
119.7236%
68.8872%
96.4067%
82.0575%
67.7969%
61.0882%
6.6463%
-9.249%
15.0268%
31.2086%
33.7669%
30.2315%
0.5048%
-17.813%
-9.7893%
-2.0678%
35.0508%
41.2295%
21.5166%
14.5001%
-28.0071%
-71.4151%
-54.4699%
-75.2137%
-75.4085%
-79.4519%
-202.6561%
-293.5188%
-379.0082%
-160.4298%
-18.7443%
26.0894%
47.4375%
27.9629%
23.1499%
30.6903%
36.0155%
40.809%
32.2575%
22.5289%
23.1903%
18.9095%
19.4223%
13.3892%
-2.4247%
-47.9257%
-95.36%
-107.9202%
-87.1039%
-5.9149%
21.5617%
29.9518%
27.0199%
4.6848%
5.6428%
7.5342%
2.2617%
-1.7898%
-6.1862%
68.4879%
72.4657%
74.5611%
74.5287%
-108.7931%
-153.9745%
-182.6999%
-208.6828%
-54.1963%
-38.7885%
-37.1954%
-44.0773%
-40.8849%
-55.3058%
-68.6939%
-81.0554%
-57.3743%
-36.3602%
-35.4384%
15.7206%
19.4704%
19.4242%
35.8097%
-28.3513%
-48.9001%
-66.1365%
-94.1425%
-36.3986%
-36.7608%
-35.6286%
-32.753%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.